Allergy Immunotherapy Industry Research Report 2023

Allergy Immunotherapy Industry Research Report 2023


Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

Highlights

The global Allergy Immunotherapy market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In EMEA, Allergy Immunotherapy main players include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, etc., totally accounting for about 98% of market. As for the types of products, it can be divided into Subcutaneous Immunotherapy and Sublingual Immunotherapy. The most common product is Subcutaneous Immunotherapy, with a share over 60%. In terms of applications, it is widely used in Allergic Rhinitis, Allergic Asthma and Others. The most application is in Allergic Rhinitis, with a share over 45%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Allergy Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Immunotherapy.
The Allergy Immunotherapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Allergy Immunotherapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergy Immunotherapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
Holister Stier
Leti

Product Type Insights

Global markets are presented by Allergy Immunotherapy type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Allergy Immunotherapy are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Allergy Immunotherapy segment by Type

Subcutaneous Immunotherapy
Sublingual Immunotherapy

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Allergy Immunotherapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Allergy Immunotherapy market.
Allergy Immunotherapy segment by Application

Allergic Rhinitis
Allergic Asthma
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Allergy Immunotherapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Immunotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Allergy Immunotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Allergy Immunotherapy industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Immunotherapy.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Allergy Immunotherapy manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Allergy Immunotherapy by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Allergy Immunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Allergy Immunotherapy Market Size (2018-2029) & (US$ Million)
2.2.2 Global Allergy Immunotherapy Sales (2018-2029)
2.2.3 Global Allergy Immunotherapy Market Average Price (2018-2029)
2.3 Allergy Immunotherapy by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
2.4 Allergy Immunotherapy by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Allergic Rhinitis
2.4.3 Allergic Asthma
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Allergy Immunotherapy Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Allergy Immunotherapy Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Allergy Immunotherapy Revenue of Manufacturers (2018-2023)
3.4 Global Allergy Immunotherapy Average Price by Manufacturers (2018-2023)
3.5 Global Allergy Immunotherapy Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Allergy Immunotherapy, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Allergy Immunotherapy, Product Type & Application
3.8 Global Manufacturers of Allergy Immunotherapy, Date of Enter into This Industry
3.9 Global Allergy Immunotherapy Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 ALK-Abello
4.1.1 ALK-Abello Company Information
4.1.2 ALK-Abello Business Overview
4.1.3 ALK-Abello Allergy Immunotherapy Sales, Revenue and Gross Margin (2018-2023)
4.1.4 ALK-Abello Allergy Immunotherapy Product Portfolio
4.1.5 ALK-Abello Recent Developments
4.2 Stallergenes Greer
4.2.1 Stallergenes Greer Company Information
4.2.2 Stallergenes Greer Business Overview
4.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Stallergenes Greer Allergy Immunotherapy Product Portfolio
4.2.5 Stallergenes Greer Recent Developments
4.3 Merck
4.3.1 Merck Company Information
4.3.2 Merck Business Overview
4.3.3 Merck Allergy Immunotherapy Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Merck Allergy Immunotherapy Product Portfolio
4.3.5 Merck Recent Developments
4.4 Allergy Therapeutics
4.4.1 Allergy Therapeutics Company Information
4.4.2 Allergy Therapeutics Business Overview
4.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Allergy Therapeutics Allergy Immunotherapy Product Portfolio
4.4.5 Allergy Therapeutics Recent Developments
4.5 HAL
4.5.1 HAL Company Information
4.5.2 HAL Business Overview
4.5.3 HAL Allergy Immunotherapy Sales, Revenue and Gross Margin (2018-2023)
6.5.4 HAL Allergy Immunotherapy Product Portfolio
6.5.5 HAL Recent Developments
4.6 Holister Stier
4.6.1 Holister Stier Company Information
4.6.2 Holister Stier Business Overview
4.6.3 Holister Stier Allergy Immunotherapy Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Holister Stier Allergy Immunotherapy Product Portfolio
4.6.5 Holister Stier Recent Developments
4.7 Leti
4.7.1 Leti Company Information
4.7.2 Leti Business Overview
4.7.3 Leti Allergy Immunotherapy Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Leti Allergy Immunotherapy Product Portfolio
4.7.5 Leti Recent Developments
5 Global Allergy Immunotherapy Market Scenario by Region
5.1 Global Allergy Immunotherapy Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Allergy Immunotherapy Sales by Region: 2018-2029
5.2.1 Global Allergy Immunotherapy Sales by Region: 2018-2023
5.2.2 Global Allergy Immunotherapy Sales by Region: 2024-2029
5.3 Global Allergy Immunotherapy Revenue by Region: 2018-2029
5.3.1 Global Allergy Immunotherapy Revenue by Region: 2018-2023
5.3.2 Global Allergy Immunotherapy Revenue by Region: 2024-2029
5.4 North America Allergy Immunotherapy Market Facts & Figures by Country
5.4.1 North America Allergy Immunotherapy Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Allergy Immunotherapy Sales by Country (2018-2029)
5.4.3 North America Allergy Immunotherapy Revenue by Country (2018-2029)
5.5 Europe Allergy Immunotherapy Market Facts & Figures by Country
5.5.1 Europe Allergy Immunotherapy Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Allergy Immunotherapy Sales by Country (2018-2029)
5.5.3 Europe Allergy Immunotherapy Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Allergy Immunotherapy Market Facts & Figures by Country
5.6.1 Asia Pacific Allergy Immunotherapy Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Allergy Immunotherapy Sales by Country (2018-2029)
5.6.3 Asia Pacific Allergy Immunotherapy Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Allergy Immunotherapy Market Facts & Figures by Country
5.7.1 Latin America Allergy Immunotherapy Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Allergy Immunotherapy Sales by Country (2018-2029)
5.7.3 Latin America Allergy Immunotherapy Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Allergy Immunotherapy Market Facts & Figures by Country
5.8.1 Middle East and Africa Allergy Immunotherapy Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Allergy Immunotherapy Sales by Country (2018-2029)
5.8.3 Middle East and Africa Allergy Immunotherapy Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Allergy Immunotherapy Sales by Type (2018-2029)
6.1.1 Global Allergy Immunotherapy Sales by Type (2018-2029) & (K Units)
6.1.2 Global Allergy Immunotherapy Sales Market Share by Type (2018-2029)
6.2 Global Allergy Immunotherapy Revenue by Type (2018-2029)
6.2.1 Global Allergy Immunotherapy Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Allergy Immunotherapy Revenue Market Share by Type (2018-2029)
6.3 Global Allergy Immunotherapy Price by Type (2018-2029)
7 Segment by Application
7.1 Global Allergy Immunotherapy Sales by Application (2018-2029)
7.1.1 Global Allergy Immunotherapy Sales by Application (2018-2029) & (K Units)
7.1.2 Global Allergy Immunotherapy Sales Market Share by Application (2018-2029)
7.2 Global Allergy Immunotherapy Revenue by Application (2018-2029)
6.2.1 Global Allergy Immunotherapy Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Allergy Immunotherapy Revenue Market Share by Application (2018-2029)
7.3 Global Allergy Immunotherapy Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Allergy Immunotherapy Value Chain Analysis
8.1.1 Allergy Immunotherapy Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Allergy Immunotherapy Production Mode & Process
8.2 Allergy Immunotherapy Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Allergy Immunotherapy Distributors
8.2.3 Allergy Immunotherapy Customers
9 Global Allergy Immunotherapy Analyzing Market Dynamics
9.1 Allergy Immunotherapy Industry Trends
9.2 Allergy Immunotherapy Industry Drivers
9.3 Allergy Immunotherapy Industry Opportunities and Challenges
9.4 Allergy Immunotherapy Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Allergy Immunotherapy Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Allergy Immunotherapy Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Allergy Immunotherapy Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Allergy Immunotherapy Revenue of Manufacturers (2018-2023)
Table 9. Global Allergy Immunotherapy Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Allergy Immunotherapy Average Price (USD/Unit) of Manufacturers (2018-2023)
Table 11. Global Allergy Immunotherapy Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Allergy Immunotherapy, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Allergy Immunotherapy by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. ALK-Abello Company Information
Table 17. ALK-Abello Business Overview
Table 18. ALK-Abello Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 19. ALK-Abello Allergy Immunotherapy Product Portfolio
Table 20. ALK-Abello Recent Developments
Table 21. Stallergenes Greer Company Information
Table 22. Stallergenes Greer Business Overview
Table 23. Stallergenes Greer Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 24. Stallergenes Greer Allergy Immunotherapy Product Portfolio
Table 25. Stallergenes Greer Recent Developments
Table 26. Merck Company Information
Table 27. Merck Business Overview
Table 28. Merck Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 29. Merck Allergy Immunotherapy Product Portfolio
Table 30. Merck Recent Developments
Table 31. Allergy Therapeutics Company Information
Table 32. Allergy Therapeutics Business Overview
Table 33. Allergy Therapeutics Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 34. Allergy Therapeutics Allergy Immunotherapy Product Portfolio
Table 35. Allergy Therapeutics Recent Developments
Table 36. HAL Company Information
Table 37. HAL Business Overview
Table 38. HAL Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 39. HAL Allergy Immunotherapy Product Portfolio
Table 40. HAL Recent Developments
Table 41. Holister Stier Company Information
Table 42. Holister Stier Business Overview
Table 43. Holister Stier Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 44. Holister Stier Allergy Immunotherapy Product Portfolio
Table 45. Holister Stier Recent Developments
Table 46. Leti Company Information
Table 47. Leti Business Overview
Table 48. Leti Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 49. Leti Allergy Immunotherapy Product Portfolio
Table 50. Leti Recent Developments
Table 51. Global Allergy Immunotherapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 52. Global Allergy Immunotherapy Sales by Region (2018-2023) & (K Units)
Table 53. Global Allergy Immunotherapy Sales Market Share by Region (2018-2023)
Table 54. Global Allergy Immunotherapy Sales by Region (2024-2029) & (K Units)
Table 55. Global Allergy Immunotherapy Sales Market Share by Region (2024-2029)
Table 56. Global Allergy Immunotherapy Revenue by Region (2018-2023) & (US$ Million)
Table 57. Global Allergy Immunotherapy Revenue Market Share by Region (2018-2023)
Table 58. Global Allergy Immunotherapy Revenue by Region (2024-2029) & (US$ Million)
Table 59. Global Allergy Immunotherapy Revenue Market Share by Region (2024-2029)
Table 60. North America Allergy Immunotherapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. North America Allergy Immunotherapy Sales by Country (2018-2023) & (K Units)
Table 62. North America Allergy Immunotherapy Sales by Country (2024-2029) & (K Units)
Table 63. North America Allergy Immunotherapy Revenue by Country (2018-2023) & (US$ Million)
Table 64. North America Allergy Immunotherapy Revenue by Country (2024-2029) & (US$ Million)
Table 65. Europe Allergy Immunotherapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. Europe Allergy Immunotherapy Sales by Country (2018-2023) & (K Units)
Table 67. Europe Allergy Immunotherapy Sales by Country (2024-2029) & (K Units)
Table 68. Europe Allergy Immunotherapy Revenue by Country (2018-2023) & (US$ Million)
Table 69. Europe Allergy Immunotherapy Revenue by Country (2024-2029) & (US$ Million)
Table 70. Asia Pacific Allergy Immunotherapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Asia Pacific Allergy Immunotherapy Sales by Country (2018-2023) & (K Units)
Table 72. Asia Pacific Allergy Immunotherapy Sales by Country (2024-2029) & (K Units)
Table 73. Asia Pacific Allergy Immunotherapy Revenue by Country (2018-2023) & (US$ Million)
Table 74. Asia Pacific Allergy Immunotherapy Revenue by Country (2024-2029) & (US$ Million)
Table 75. Latin America Allergy Immunotherapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Latin America Allergy Immunotherapy Sales by Country (2018-2023) & (K Units)
Table 77. Latin America Allergy Immunotherapy Sales by Country (2024-2029) & (K Units)
Table 78. Latin America Allergy Immunotherapy Revenue by Country (2018-2023) & (US$ Million)
Table 79. Latin America Allergy Immunotherapy Revenue by Country (2024-2029) & (US$ Million)
Table 80. Middle East and Africa Allergy Immunotherapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Middle East and Africa Allergy Immunotherapy Sales by Country (2018-2023) & (K Units)
Table 82. Middle East and Africa Allergy Immunotherapy Sales by Country (2024-2029) & (K Units)
Table 83. Middle East and Africa Allergy Immunotherapy Revenue by Country (2018-2023) & (US$ Million)
Table 84. Middle East and Africa Allergy Immunotherapy Revenue by Country (2024-2029) & (US$ Million)
Table 85. Global Allergy Immunotherapy Sales by Type (2018-2023) & (K Units)
Table 86. Global Allergy Immunotherapy Sales by Type (2024-2029) & (K Units)
Table 87. Global Allergy Immunotherapy Sales Market Share by Type (2018-2023)
Table 88. Global Allergy Immunotherapy Sales Market Share by Type (2024-2029)
Table 89. Global Allergy Immunotherapy Revenue by Type (2018-2023) & (US$ Million)
Table 90. Global Allergy Immunotherapy Revenue by Type (2024-2029) & (US$ Million)
Table 91. Global Allergy Immunotherapy Revenue Market Share by Type (2018-2023)
Table 92. Global Allergy Immunotherapy Revenue Market Share by Type (2024-2029)
Table 93. Global Allergy Immunotherapy Price by Type (2018-2023) & (USD/Unit)
Table 94. Global Allergy Immunotherapy Price by Type (2024-2029) & (USD/Unit)
Table 95. Global Allergy Immunotherapy Sales by Application (2018-2023) & (K Units)
Table 96. Global Allergy Immunotherapy Sales by Application (2024-2029) & (K Units)
Table 97. Global Allergy Immunotherapy Sales Market Share by Application (2018-2023)
Table 98. Global Allergy Immunotherapy Sales Market Share by Application (2024-2029)
Table 99. Global Allergy Immunotherapy Revenue by Application (2018-2023) & (US$ Million)
Table 100. Global Allergy Immunotherapy Revenue by Application (2024-2029) & (US$ Million)
Table 101. Global Allergy Immunotherapy Revenue Market Share by Application (2018-2023)
Table 102. Global Allergy Immunotherapy Revenue Market Share by Application (2024-2029)
Table 103. Global Allergy Immunotherapy Price by Application (2018-2023) & (USD/Unit)
Table 104. Global Allergy Immunotherapy Price by Application (2024-2029) & (USD/Unit)
Table 105. Key Raw Materials
Table 106. Raw Materials Key Suppliers
Table 107. Allergy Immunotherapy Distributors List
Table 108. Allergy Immunotherapy Customers List
Table 109. Allergy Immunotherapy Industry Trends
Table 110. Allergy Immunotherapy Industry Drivers
Table 111. Allergy Immunotherapy Industry Restraints
Table 112. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Allergy ImmunotherapyProduct Picture
Figure 5. Global Allergy Immunotherapy Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Allergy Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 7. Global Allergy Immunotherapy Sales (2018-2029) & (K Units)
Figure 8. Global Allergy Immunotherapy Average Price (USD/Unit) & (2018-2029)
Figure 9. Subcutaneous Immunotherapy Product Picture
Figure 10. Sublingual Immunotherapy Product Picture
Figure 11. Allergic Rhinitis Product Picture
Figure 12. Allergic Asthma Product Picture
Figure 13. Others Product Picture
Figure 14. Global Allergy Immunotherapy Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Allergy Immunotherapy, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Allergy Immunotherapy, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Allergy Immunotherapy Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Allergy Immunotherapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Allergy Immunotherapy Sales by Region in 2022
Figure 21. Global Allergy Immunotherapy Revenue by Region in 2022
Figure 22. North America Allergy Immunotherapy Market Size by Country in 2022
Figure 23. North America Allergy Immunotherapy Sales Market Share by Country (2018-2029)
Figure 24. North America Allergy Immunotherapy Revenue Market Share by Country (2018-2029)
Figure 25. Europe Allergy Immunotherapy Market Size by Country in 2022
Figure 26. Europe Allergy Immunotherapy Sales Market Share by Country (2018-2029)
Figure 27. Europe Allergy Immunotherapy Revenue Market Share by Country (2018-2029)
Figure 28. Germany Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Allergy Immunotherapy Market Size by Country in 2022
Figure 34. Asia Pacific Allergy Immunotherapy Sales Market Share by Country (2018-2029)
Figure 35. Asia Pacific Allergy Immunotherapy Revenue Market Share by Country (2018-2029)
Figure 36. China Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Allergy Immunotherapy Market Size by Country in 2022
Figure 46. Latin America Allergy Immunotherapy Sales Market Share by Country (2018-2029)
Figure 47. Latin America Allergy Immunotherapy Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East and Africa Allergy Immunotherapy Market Size by Country in 2022
Figure 52. Middle East and Africa Allergy Immunotherapy Sales Market Share by Country (2018-2029)
Figure 53. Middle East and Africa Allergy Immunotherapy Revenue Market Share by Country (2018-2029)
Figure 54. Turkey Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. UAE Allergy Immunotherapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Global Allergy Immunotherapy Sales Market Share by Type (2018-2029)
Figure 58. Global Allergy Immunotherapy Revenue Market Share by Type (2018-2029)
Figure 59. Global Allergy Immunotherapy Price (USD/Unit) by Type (2018-2029)
Figure 60. Global Allergy Immunotherapy Sales Market Share by Application (2018-2029)
Figure 61. Global Allergy Immunotherapy Revenue Market Share by Application (2018-2029)
Figure 62. Global Allergy Immunotherapy Price (USD/Unit) by Application (2018-2029)
Figure 63. Allergy Immunotherapy Value Chain
Figure 64. Allergy Immunotherapy Production Mode & Process
Figure 65. Direct Comparison with Distribution Share
Figure 66. Distributors Profiles
Figure 67. Allergy Immunotherapy Industry Opportunities and Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings